Ophthalmology Times Europe December 2023

Real-world data from using faricimab to treat neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DME)

The technology provides effective, efficient evaluations when paired with the right patients

In 2024, the waiting game will pay off for glaucoma specialists who are eager to develop fluency and implement new devices into their practices

Analysis suggested no evidence for a causal association of lifetime cannabis use and cannabis use disorder with primary open-angle glaucoma

The case for treating keratoconus without waiting for disease progression

Why “acceleration” is the industry keyword for 2024

Working smarter, not harder, to benefit patients

Orbis advances cataract surgery training in low-resource areas with technology

Experts from around the globe converged in San Francisco, California

Restoration and regeneration represent a new paradigm

At this year’s EURETINA meeting, retina specialists highlighted important developments in diabetic macular oedema and diabetic retinopathy research

Data show transfection in both eyes despite unilateral injection